Online course seeks to address opioid deaths in adolescents
Mar. 9, 2023—Vanderbilt is providing a short online course for educators that seeks to address opioid overdose deaths among adolescents.
Complementary research, resources, policies improve outcomes for those with substance use disorders: Panel
Sep. 14, 2022—A panel of experts on opioid use disorder (OUD) recently discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic.
Difficulty swallowing linked to chronic opioid use: study
Jul. 21, 2022—Vanderbilt researchers found that chronic use of opioid painkillers like hydrocodone and oxycodone significantly increases the risk of dysphagia, or difficulty swallowing.
Filling multiple opioid prescriptions after childbirth associated with maternal death risk
Jun. 9, 2022—In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.
Pushing (anti-overdose) drugs
May. 23, 2022—An automated alert to encourage clinicians to coprescribe naloxone for patients at risk of opioid overdose increased naloxone prescriptions per opioid prescription 16-fold.
New model helps expand opioid use care options
Feb. 3, 2022—Vanderbilt is using an innovative hub and spoke treatment model to care for patients with opioid use disorder.
Opioid use disorder treatment access increases in areas with large Medicaid population
Jan. 4, 2022— by Jill Clendening Researchers report that in communities where Medicaid is a more common source of insurance, providers of buprenorphine, an effective treatment for opioid use disorder (OUD), are much less likely to discriminate between Medicaid and privately insured prospective patients, but patients with either type of coverage still face many barriers to obtaining...
Artificial intelligence predicts opioid overdose in Tennessee
Oct. 19, 2021—Researchers at Vanderbilt and the Tennessee Department of Health have developed 30-day predictive models for fatal and non-fatal opioid-related overdose among patients receiving opioid prescriptions in the state.
Study finds increased risk of serious opioid events in mothers, regardless of dose
Apr. 26, 2021—A new study from Vanderbilt University Medical Center researchers finds that new mothers who receive opioids after uncomplicated vaginal births face an increased risk of serious opioid-related events regardless of the opioid dosage, a finding that could significantly impact care delivery.
Codeine metabolizer status in clinical practice
Apr. 5, 2021—Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine.
Program using telehealth to treat Opioid Use Disorder
Feb. 11, 2021—The Vanderbilt Maternal Addiction Recovery Program (VMARP) is offering virtual appointments to help reach patients in Nashville’s outlying areas for treatment of Opioid Use Disorder (OUD).
Study shows drastic increases in opioid-affected births
Jan. 12, 2021—The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.